Results 15,041-15,060 of 27,076 for speaker:Richard Boyd Barrett
- Protection of Life During Pregnancy (Amendment) Bill 2017: Second Stage [Private Members] (7 Mar 2017)
Richard Boyd Barrett: It is difficult, given the context in which this debate is taking place, not to remark on the extraordinary inconsistency of people who oppose women having the right to choose abortion and to control their own bodies and lives on the grounds they are concerned for the life of unborn children when the very same people stood by while babies and their mothers were treated in an absolutely...
- Ceisteanna - Questions: Cabinet Committee Meetings (7 Mar 2017)
Richard Boyd Barrett: The Taoiseach would want to read the small print from Irish Water.
- Ceisteanna - Questions: Cabinet Committee Meetings (7 Mar 2017)
Richard Boyd Barrett: Where are the real conservation grants?
- Ceisteanna - Questions: Cabinet Committee Meetings (7 Mar 2017)
Richard Boyd Barrett: What discussions has the Taoiseach had about our water infrastructure at the aforementioned committee? Over the past number of years, the Taoiseach has tried to justify domestic water charges on the basis that we urgently need to address the huge problems with our water infrastructure and to comply with EU directives in the context of the management of our water resources. I do not give...
- Ceisteanna - Questions: Cabinet Committee Meetings (7 Mar 2017)
Richard Boyd Barrett: I wish the Government was-----
- Ceisteanna - Questions: Cabinet Committee Meetings (7 Mar 2017)
Richard Boyd Barrett: 5. To ask the Taoiseach when the Cabinet committee on infrastructure, environment and climate action last met. [10043/17]
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: I will start with the recommendations made by the HPRA. Dr. Nolan mentioned that the Netherlands, Italy and the Czech Republic have all followed an approached access to medicinal cannabis. It is more extensive than the programme proposed by the HPRA and is in line with the proposals for access contained in Deputy Gino Kenny's Bill. The HPRA has chosen a more conservative approach than the...
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: We do the same on Committee Stage.
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: The authors of the Bill have made it clear from the outset that we understand the rescheduling of cannabis would have to happen. Any suggestion we simply want to decriminalise cannabis is not true. We have made it absolutely clear to the Department, and anybody with whom we have discussed it, that we did not feel qualified to make a decision about precisely how to reschedule it, but we have...
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: Where is that set down?
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: By?
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: Two of my questions were not answered at all. Why has pain been left out? Can Dr. Nolan respond to the points made by Professor Finn that I read to her? I want to stress this, particularly after Dr. Breslin's intervention. Professor Finn said that the long list of adverse side effects of recreational cannabis use have very little to do with what we are discussing here, which is about...
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: Professor Finn is saying that.
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: On the points Dr. Nolan is making, Professor David Finn makes exactly the same points about what we do know. I take the point that we do not have all of the evidence. He said, in response to the exact point Dr. Nolan is making, the cases of pain could be diverse, but we know that peripheral and central sensitisation are the neurobiological mechanisms underlying most types of chronic pain...
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: Does Dr. Nolan disagree with what Professor David Finn said?
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: Should they not be included in the trial and not excluded, as proposed?
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: Professor David Finn does not agree.
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: I thank the witnesses for the lengthy briefing. I hope there is agreement on it but, as we are concluding, it would be helpful to clarify or acknowledge that the job of the HPRA is, as I understand it, to work within certain EU directives and frameworks to approve a drug to be used an dispensed. As I understand it, it is not about deciding the efficacy of a particular product for a...
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: That would no longer apply if the legislation was changed.
- Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)
Richard Boyd Barrett: Do we need legislative change?